We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
111 hedge funds and large institutions have $831M invested in Madrigal Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
74% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 27
0.17% more ownership
Funds ownership: 62.32% → 62.49% (+0.17%)
4% less funds holding
Funds holding: 116 → 111 (-5)
17% less capital invested
Capital invested by funds: $1.01B → $831M (-$176M)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less call options, than puts
Call options by funds: $6.99M | Put options by funds: $14.2M
Holders
111
Holders Change
-5
Holders Change %
-4.31%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
47
Reduced
27
Closed
17
Calls
$6.99M
Puts
$14.2M
Net Calls
-$7.23M
Net Calls Change
-$2.28M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$71.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.67M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.45M |
| 4 |
SG Americas Securities
New York
|
+$2.23M |
| 5 |
Morgan Stanley
New York
|
+$1.92M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$28.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$10.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.29M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.36M |
